BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/15/2020 12:00:00 PM | Browse: 720 | Download: 799
 |
Received |
|
2020-01-02 13:47 |
|
Peer-Review Started |
|
2020-01-02 13:47 |
|
To Make the First Decision |
|
2020-02-24 12:40 |
|
Return for Revision |
|
2020-02-27 10:58 |
|
Revised |
|
2020-03-03 09:38 |
|
Second Decision |
|
2020-03-25 09:12 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-03-26 13:21 |
|
Articles in Press |
|
2020-03-26 13:21 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-04-14 01:30 |
|
Publish the Manuscript Online |
|
2020-04-15 12:00 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Efficacy of mesenchymal stem cells in the treatment of gastrointestinal malignancies
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jian-Nan Li, Wei Li, Lan-Qing Cao, Ning Liu and Kai Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Kai Zhang, MD, PhD, Chief Doctor, Professor, Department of General Surgery, The Second Hospital of Jilin University, 218 Ziqiang Street, Changchun 130041, Jilin Province, China. zhang_kai@jlu.edu.cn |
| Key Words |
Mesenchymal stem cells; Gastrointestinal malignancies; Gastric cancer; Hepatoma; Pancreatic cancer; Colorectal cancer |
| Core Tip |
Mesenchymal stem cells (MSCs) possess immune privileged nature, tumor homing feature, and multi-lineage differentiation ability. Gastrointestinal (GI) malignancies are the major causes of cancer-related death worldwide. The interactions of MSCs and GI cancer cells in specific conditions have attracted more and more attentions. In this review, we would like to introduce the characteristics of MSCs and analyse the effects of MSCs on GI malignancies. In addition, we also provide our perspectives on the reason why MSCs may play different roles in GI malignancies and further research directions to increase the treatment efficacy of MSCs on GI malignancies. |
| Publish Date |
2020-04-15 12:00 |
| Citation |
Li JN, Li W, Cao LQ, Liu N, Zhang K. Efficacy of mesenchymal stem cells in the treatment of gastrointestinal malignancies. World J Gastrointest Oncol 2020; 12(4): 365-382 |
| URL |
https://www.wjgnet.com/1948-5204/full/v12/i4/365.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v12.i4.365 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
